INDENTURE amongIndenture • September 2nd, 2003 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 2nd, 2003 Company Industry Jurisdiction
EXHIBIT 1.1 [FORM OF UNDERWRITING AGREEMENT] UNDERWRITING AGREEMENTUnderwriting Agreement • September 2nd, 2003 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 2nd, 2003 Company Industry Jurisdiction
INDENTURE amongIndenture • September 2nd, 2003 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 2nd, 2003 Company Industry Jurisdiction
UNDERWRITING AGREEMENT among GLAXOSMITHKLINE CAPITAL INC. as Issuer GLAXOSMITHKLINE PLC as Guarantor and as Representatives of the Underwriters Dated as of [ ], 20[ ]Underwriting Agreement • March 28th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 28th, 2018 Company Industry JurisdictionNote: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
UNDERWRITING AGREEMENT among GLAXOSMITHKLINE CAPITAL plc as Issuer GSK plc as Guarantor and as Representatives of the Underwriters Dated as of [ ], 20[ ]Underwriting Agreement • March 25th, 2024 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 25th, 2024 Company Industry Jurisdiction
ContractSupplemental Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionSECOND SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital Inc., a corporation organized under the laws of the State of Delaware (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).
ContractSupplemental Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital plc, a public limited company incorporated under the laws of England and Wales (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).
ContractSupplemental Indenture • March 21st, 2014 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, between GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales (the “Company”) and Law Debenture Trust Company of New York, a company duly organized and existing under the laws of the State of New York (the “Trustee”).
UNDERWRITING AGREEMENT between GSK plc as Issuer and as Representatives of the Underwriters Dated as of [ ], 20[ ]Underwriting Agreement • March 25th, 2024 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 25th, 2024 Company Industry Jurisdiction
ContractThird Supplemental Indenture • May 15th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2018 Company Industry JurisdictionTHIRD SUPPLEMENTAL INDENTURE dated as of May 15, 2018, among GlaxoSmithKline Capital Inc., a corporation organized under the laws of the State of Delaware (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas, a New York banking corporation duly organized and existing under the laws of New York (the “Trustee”) (as successor to Law Debenture Trust Company of New York, (the “Former Trustee”) which was a successor to Citibank, N.A. (the “Original Trustee” )).
UNDERWRITING AGREEMENT between GLAXOSMITHKLINE PLC as Issuer and as Representatives of the Underwriters Dated as of [ ], 20[ ]Underwriting Agreement • March 28th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 28th, 2018 Company Industry Jurisdiction
ContractSecond Supplemental Indenture • May 15th, 2018 • Glaxosmithkline Capital Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2018 Company Industry JurisdictionSECOND SUPPLEMENTAL INDENTURE dated as of May 15, 2018, among GlaxoSmithKline Capital plc, a public limited company incorporated under the laws of England and Wales (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas, a New York banking corporation duly organized and existing under the laws of New York (the “Trustee”) (as successor to Law Debenture Trust Company of New York, (the “Former Trustee”) which was a successor to Citibank, N.A. (the “Original Trustee” ).